From: Use of 55 PET radiotracers under approval of a Radioactive Drug Research Committee (RDRC)
Radiotracer | Injected Dose (MBq) | Mass dose limit | Number of subjects scanned | Clinically detectable pharmacological effects in humans |
---|---|---|---|---|
[11C]Radiotracers | ||||
 [11C]ACE | 740 | None | 475 | No |
 [11C]ACHC | 740 | ≤5000 μg/subject | 2 | No |
 [11C]BMP | 444 | ≤4625 μg/subject | 65 | No |
 [11C]BUT | 555 | ≤125 μg/kg | 0a | a |
 [11C]CFN | 555 | ≤0.03 μg/kg | 1492 | No |
 [11C]CHO | 592 | None | 44 | No |
 [11C]DASB | 666 | ≤8 μg/subject | 179 | No |
 [11C]DTBZ | 555 | ≤50 μg/subject | 1823 | No |
 [11C]EPI | 740 | < 9 μg/subject epinephrine & ≤1 μg/subject norepinephrine precursor | 96 | No |
 [11C]FMZ | 370 | ≤50 μg/subject | 668 | No |
 [11C]HED | 666 | ≤50 μg/subjectb | 643 | No |
 [11C]LY2795050 | 555 | ≤10 μg/subject | 0c | c |
 [11C]MET | 444 | None | 129 | No |
 [11C]MTBZ | 580 | ≤10 μg/subject | 6 | No |
 [11C]MPH | 666 | ≤25 μg/subject | 170 | No |
 [11C]NMBP | 740–1480 | ≤127 μg/subjectd | 59 | No |
 [11C]OMAR | 666 | 0.14 μg/kg | 0e | e |
 [11C]PALM | 740 | None | 8 | No |
 [11C]PBR28 | 666 | ≤10 μg/subject | 34 | No |
 [11C]PiB | 666 | ≤13 μg/subject | 592 | No |
 [11C]PE2I | 555 | ≤6.3 μg/subject | 1 | No |
 [11C]PHEN | 740 | ≤6800 μg/subject | 29 | No |
 [11C]PK11195 | 888 | ≤420 μg/subject | 118 | No |
 [11C]PMP | 555 | ≤200 μg/subject | 801 | No |
 [11C]RAC | 555 | ≤50 μg/subject | 627 | No |
 [11C]Ro-54,864 | 555 | ≤160 μg/subject | 6 | No |
 [11C]SARC | 592 | None | 20 | No |
 [11C]SCOP | 1480 | ≤50 μg/subject | 14 | No |
 [11C]TBZ | 1018 | ≤10 μg/subject | 2 | No |
 [11C]TRB | 1110 | ≤31 μg/subject | 26 | No |
 [11C]WAY-100365 | 555 | ≤15 μg/subject | 51 | No |
[18F]Radiotracers | ||||
 [18F]AV1451 | 370 | ≤20 μg/subject | 92 | No |
 [18F]ASEM | 370 | ≤0.67 μg/subject | 1 | No |
 Auxumin | 370 | ≤20 μg/subject | 228f | No |
 [18F]FAZA | 296 | ≤3.5 μg/subject | 14 | No |
 [18F]FDG | 185–296 | None | 6804 | No |
 [18F]FDOPA | 148 | ≤15 μg/subject | 0g | g |
 [18F]FEOBV | 296 | ≤1.23 μg/subject | 308 | No |
 [18F]FCH | 222 | ≤100 μg/subject | 67 | No |
 Amyvid | 370 | ≤50 μg/subject | 222 | No |
 [18F]FLT | 370 | ≤20 μg/subject | 8 | No |
 [18F]FLBT | 296 | ≤0.02 μg/kg | 92 | No |
 Vizamyl | 370 | ≤20 μg/subject | 11 | No |
 [18F]FMISO | 370 | ≤15 μg/subject | 8 | No |
 [18F]FP-TBZ | 370 | ≤7.5 μg/subject | 23 | No |
 [18F]GBR | 148 | ≤900 μg/subject | 2 | No |
 [18F]MHPG | 241 | ≤10 μg/subject | 17 | No |
 [18F]MPPF | 259 | ≤2 μg/subject | 34 | No |
 [18F]NaF | 222 | None | 9 | No |
 [18F]NML | 370 | ≤10 μg/subject | 6 | No |
 [18F]PHPG | 241 | ≤10 μg/subject | 15 | No |
Other Radiotracers | ||||
 [13N]NH3 | 740 | None | 1472 | No |
 [15O]Water | 555 | None | 1153 | No |
 NETSPOT | 200 | ≤40 μg/subject | 981f | No |
 [68Ga]PSMA-11 | 185 | ≤10 μg/subject | 751f | No |